In the previous funding cycle, we developed and applied a chemical biology tool called `bipartite Cys4 display'. Bipartite Cys4 display provides structural information about intact proteins that NMR and crystallography cannot and under conditions where structural dynamics are visible. It operates in cells and on targets, like recepto tyrosine kinases, whose dynamic structure is tied intimately to function. With this tool, we gained critical insights into how one receptor tyrosine kinase, the epidermal growth factor receptor (EGFR), an exceptionally important cancer target, communicates chemical information across the plasma membrane. These insights led to molecules-cell penetrating, hydrocarbon-stapled peptides-that inhibit EGFR, in cells, in a new way, via allostery. We also serendipitously discovered novel, allosteric EGFR activators. We learned that growth factor binding to EGFR on the cell surface induces growth factor-dependent coiled coils in the cytoplasmic juxtamembrane segment (JM) that are linked to kinase activation. In this renewal, we first apply state-of-the art structural and computational methods to improve potency and selectivity for activated and drug-resistant (L858R/T790M) EGFR and elucidate the mechanism of EGFR activators for wound healing applications. We build on our discovery that WT, activated, and L858R/T790M EGFR (DM EGFR) differ in a previously unrecognized way- their JM segments contain different coiled coils. This difference provides a path towards molecules that selectively inhibit DM EGFR, alone or synergistically in combination with small molecule tyrosine kinase inhibitors. Next, we interrogate how EGFR decodes JM structure into ligand-dependent biology, and finally broaden our focus to include the heterodimeric ErbB2/3, of great current interest in breast cancer. This work will provide fundamental information on one of the most elusive of all protein functions-allostery-in the context of one of most important human oncogene family-EGFR. We will learn how allostery encodes chemical and mutational information in ErbB proteins, how this information is transmitted into biologic function, and how knowledge of allosteric transitions can guide the design of potent, selective inhibitors (or inhibitor combinations) with novel and needed activities.

Public Health Relevance

This work will provide fundamental information on one of the most elusive of all protein functions-allostery-in the context of an exceptionally important human oncogene family-EGFR. We will learn how allostery encodes chemical and mutational information in ErbB proteins, how this information is transmitted into biologic function and how knowledge of allosteric transitions can guide the design of potent, selective inhibitors (or inhibitor combinations) with novel and needed activities. Our hope and expectation is that the knowledge gained will validate oligomer modulation as a viable therapeutic strategy, even beyond the ErbB family, and begin to illuminate the magic of dynamic membrane protein function.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM083257-10
Application #
9458201
Study Section
Synthetic and Biological Chemistry A Study Section (SBCA)
Program Officer
Bond, Michelle Rueffer
Project Start
2008-05-01
Project End
2019-03-31
Budget Start
2018-04-01
Budget End
2019-03-31
Support Year
10
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Yale University
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
043207562
City
New Haven
State
CT
Country
United States
Zip Code
Sinclair, Julie K L; Walker, Allison S; Doerner, Amy E et al. (2018) Mechanism of Allosteric Coupling into and through the Plasma Membrane by EGFR. Cell Chem Biol 25:857-870.e7
Erdmann, Roman S; Toomre, Derek; Schepartz, Alanna (2017) STED Imaging of Golgi Dynamics with Cer-SiR: A Two-Component, Photostable, High-Density Lipid Probe for Live Cells. Methods Mol Biol 1663:65-78
Takakura, Hideo; Zhang, Yongdeng; Erdmann, Roman S et al. (2017) Long time-lapse nanoscopy with spontaneously blinking membrane probes. Nat Biotechnol 35:773-780
Thompson, Alexander D; Bewersdorf, Joerg; Toomre, Derek et al. (2017) HIDE Probes: A New Toolkit for Visualizing Organelle Dynamics, Longer and at Super-Resolution. Biochemistry 56:5194-5201
Bottanelli, Francesca; Kilian, Nicole; Ernst, Andreas M et al. (2017) A novel physiological role for ARF1 in the formation of bidirectional tubules from the Golgi. Mol Biol Cell 28:1676-1687
Thompson, Alexander D; Omar, Mitchell H; Rivera-Molina, Felix et al. (2017) Long-Term Live-Cell STED Nanoscopy of Primary and Cultured Cells with the Plasma Membrane HIDE Probe DiI-SiR. Angew Chem Int Ed Engl 56:10408-10412
Walker, Allison S; Rablen, Paul R; Schepartz, Alanna (2016) Rotamer-Restricted Fluorogenicity of the Bis-Arsenical ReAsH. J Am Chem Soc 138:7143-50
Bottanelli, Francesca; Kromann, Emil B; Allgeyer, Edward S et al. (2016) Two-colour live-cell nanoscale imaging of intracellular targets. Nat Commun 7:10778
Lowder, Melissa A; Doerner, Amy E; Schepartz, Alanna (2015) Structural Differences between Wild-Type and Double Mutant EGFR Modulated by Third-Generation Kinase Inhibitors. J Am Chem Soc 137:6456-9
Doerner, Amy; Scheck, Rebecca; Schepartz, Alanna (2015) Growth Factor Identity Is Encoded by Discrete Coiled-Coil Rotamers in the EGFR Juxtamembrane Region. Chem Biol 22:776-84

Showing the most recent 10 out of 23 publications